Analyst Recommendations

Buy Recommendation Issued On ORCL By Cowen & Co.
Cowen & Co. analyst issues BUY recommendation for ORCL on March 6, 2026 12:49PM ET. The previous analyst recommendation was Buy.ORCL was trading at $154.67 at issue of...

March 6, 2026   ORCL -1.21%

Underweight Recommendation Issued On JD By Morgan Stanley
Morgan Stanley analyst issues UNDERWEIGHT recommendation for JD on March 5, 2026 09:30PM ET. The previous analyst recommendation was Underweight.JD was trading at $25.47 at issue of the...

March 5, 2026   JD 2.39%

Buy Recommendation Issued On JD By Bank of America Securities
Bank of America Securities analyst issues BUY recommendation for JD on March 5, 2026 09:50PM ET. The previous analyst recommendation was Buy.JD was trading at $25.47 at issue...

March 5, 2026   JD 2.39%

Buy Recommendation Issued On KR By Jefferies
Jefferies analyst issues BUY recommendation for KR on March 5, 2026 10:33PM ET. The previous analyst recommendation was Buy.KR was trading at $71.57 at issue of the analyst...

March 5, 2026   KR 1.61%

Buy Recommendation Issued On MSFT By Jefferies
Jefferies analyst issues BUY recommendation for MSFT on March 5, 2026 10:30PM ET. The previous analyst recommendation was Buy.MSFT was trading at $410.68 at issue of the analyst...

March 5, 2026   MSFT -3.72%

Neutral Recommendation Issued On JD By Macquarie
Macquarie analyst issues NEUTRAL recommendation for JD on March 5, 2026 09:05PM ET. The previous analyst recommendation was Neutral.JD was trading at $25.47 at issue of the analyst...

March 5, 2026   JD 2.39%

Buy Recommendation Issued On ORCL By Jefferies
Jefferies analyst issues BUY recommendation for ORCL on March 5, 2026 09:08PM ET. The previous analyst recommendation was Buy.ORCL was trading at $154.67 at issue of the analyst...

March 5, 2026   ORCL -1.21%

Outperform Recommendation Issued On KR By Wolfe Research
Wolfe Research analyst issues OUTPERFORM recommendation for KR on March 5, 2026 05:06PM ET. The previous analyst recommendation was Outperform.KR was trading at $71.49 at issue of the...

March 5, 2026   KR 1.61%

Outperform Recommendation Issued On CVS By Leerink Partners
Leerink Partners analyst issues OUTPERFORM recommendation for CVS on March 5, 2026 03:24PM ET. The previous analyst recommendation was Outperform.CVS was trading at $79.15 at issue of the...

March 5, 2026   CVS -0.63%

Strong Buy Recommendation Issued On NVDA By Tigress Financial
Tigress Financial analyst issues STRONG BUY recommendation for NVDA on March 5, 2026 03:31PM ET. The previous analyst recommendation was Strong Buy.NVDA was trading at $179.03 at issue...

March 5, 2026   NVDA -4.10%